- 0 resultaten
laagste prijs: € 139,09, hoogste prijs: € 181,89, gemiddelde prijs: € 167,62
1
Cancer Drug Discovery - Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan Kim
bestellen
bij Springer.com
€ 181,89
bestellen
Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan Kim:

Cancer Drug Discovery - pocketboek

ISBN: 9789402414172

The reader will discover a comprehensive and multifaceted overview of the history of the development of anticancer drugs deeply influenced by the cell concept of cancer and future directi… Meer...

  - new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
2
Cancer Drug Discovery - Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan kim
bestellen
bij lehmanns.de
€ 139,09
verzending: € 0,00
bestellen

Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan kim:

Cancer Drug Discovery - pocketboek

2018, ISBN: 9789402414172

Science and History, Buch, Softcover, Softcover reprint of the original 1st ed. 2016, [PU: Springer], Springer, 2018

Verzendingskosten:Versand in 10-15 Tagen. (EUR 0.00)
3
Cancer Drug Discovery - Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan kim
bestellen
bij lehmanns.de
€ 181,89
verzending: € 0,00
bestellen
Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan kim:
Cancer Drug Discovery - pocketboek

2018

ISBN: 9789402414172

Science and History, Softcover reprint of the original 1st ed. 2016, Softcover, Buch, [PU: Springer]

  - Verzendingskosten:Versand in 10-15 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
Betaalde advertentie

Bijzonderheden over het boek

Gedetalleerde informatie over het boek. - Cancer Drug Discovery


EAN (ISBN-13): 9789402414172
pocket book
Verschijningsjaar: 2018
Uitgever: Springer

Boek bevindt zich in het datenbestand sinds 2018-10-28T09:43:31+01:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2021-09-17T13:36:31+02:00 (Amsterdam)
ISBN/EAN: 9789402414172

ISBN - alternatieve schrijfwijzen:
978-94-024-1417-2


Gegevens van de uitgever

Auteur: Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan Kim
Titel: Cancer Drug Discovery - Science and History
Uitgeverij: Springer; Springer Netherland
276 Bladzijden
Verschijningsjaar: 2018-07-05
Dordrecht; NL
Gedrukt / Gemaakt in
Gewicht: 0,615 kg
Taal: Engels
139,09 € (DE)
142,99 € (AT)
153,50 CHF (CH)
POD

BC; Previously published in hardcover; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; Verstehen; History of Cancer Drugs; Cancer Therapy Development; Adverse Effects of Anticancer Drugs; Cell Concept of Cancer; Systemic Concept of Cancer; B; Cancer Research; Pharmacy; History of Medicine; Cancer Biology; Pharmacy; History of Medicine; Biomedical and Life Sciences; Pharmazie, Apotheke; Geschichte der Medizin; BB

Part Ⅰ. A Scientific Overview on Cancer.- 1. Advancements in Life Sciences and Characteristic Features of Cancer Cells.- 1.1 Characteristics of cancer cells.- 1.2 Characteristic interactions of cancer cells with neighboring cells and the tumor microenvironment.- 2. Advancement of the Science and History of Cancer and Anticancer Drugs.- Part Ⅱ. Cancer Drug Discovery – Types and History.- 3. Chronology of Anticancer Drug Development.- 3.1 A historical background of cancer chemotherapy.- 3.2 Development of the anticancer drug screening systems.- 3.3 Chronology of the anticancer drug development.- 3.4 Clinical application of anticancer drugs.- 4. Alkylating Anticancer Drugs.- 4.1 Classical alkylating drugs.- 4.2 Nonclassical alkylating drugs.- 4.3 Alkylating-like agents: platinum compounds.- 5. Antimetabolic Anticancer Drugs.- 5.1 Folic acid derivatives.- 5.2 Purine analogs.- 5.3 Pyrimidine analogs.- 6. Natural Product Anticancer Drugs.- 6.1 Plant-derived anticancer drugs.- 6.2 Anticancer antibiotics.- 7. Immunotherapeutic Anticancer Drugs and Other Miscellaneous Anticancer Drugs.- 7.1 Immunotherapeutic anticancer drugs.- 7.2 Other miscellaneous anticancer drugs.- 8. Hormonal Anticancer Drugs.- 8.1 Hormonal anti-prostate-cancer drugs.- 8.2 Hormonal anti-breast-cancer drugs.- 8.3 Other hormonal anticancer drugs.- 9. Molecular Targeted Anticancer Drugs.- 9.1 Tretinoin (all-trans retinoic acid, ATRA).- 9.2 Bcr-Abl Inhibitors.- 9.3 EGFR inhibitors.- 9.4 HER2 inhibitors.- 9.5 Angiogenesis inhibitors.- 9.6 Other kinase inhibitors.- 9.7 mTOR inhibitors.- 9.8 Other targeted anticancer antibody drugs.- 9.9 Epigenetic anticancer drugs.- 9.10 Proteasome inhibitors.- 9.11 Vismodegib: hedgehog pathway blocker.- 10. Complications of Anticancer Drugs and Their Management.- 10.1 Chemotherapy-induced nausea and vomiting (CINV).- 10.2 Myelotoxicity (bone marrow toxicity).- 10.3 Chemotherapy-induced diarrhea.- 10.4 Chemotherapy-induced constipation.- 10.5 Chemotherapy-induced urinary toxicity.- 10.6 Chemotherapy-induced pulmonary toxicity.- 10.7 Chemotherapy-induced neurotoxicity.- 10.8 Chemotherapy-induced neurotoxicity.- 10.9 Chemotherapy-induced oral mucositis.- 10.10 Anorexia.- 10.11 Tumor lysis syndrome.- 10.12 Extravasation of anticancer drugs.- 10.13 Chemotherapy-induced skin toxicity.- Part Ⅲ. A Paradigm Shift in Cancer Research.- 11. Advancements in Bioscience and New Cancer Drugs.- 11.1. Development of cancer drugs according to scientific advancements.- 11.2. New anticancer drugs.

Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:

Laatste soortgelijke boek:
9789402408423 Cancer Drug Discovery (Kyu-Won Kim; Jae Kyung Roh; Hee-Jun Wee; Chan kim)


< naar Archief...